Cancer Cachexia: Cause, Diagnosis, and Treatment

Area of Science:

• Oncology
• Metabolism
• Nutrition Science

Background:

• Cancer patients often experience unintended weight loss due to GI dysfunction or other symptoms like anorexia.
• Cancer cachexia (CC) is a complex syndrome involving muscle loss, anorexia, fatigue, and reduced quality of life (QOL).
• CC negatively impacts treatment tolerance and patient survival, driven by tumor-induced metabolic changes, inflammation, and neurohormonal responses.

Purpose of the Study:

• To review the current understanding and management strategies for cancer cachexia.
• To highlight the importance of early nutrition screening and assessment in cancer care.
• To discuss pharmacologic approaches for treating CC, focusing on appetite and metabolic abnormalities.

Main Methods:

• Literature review of cancer cachexia, its mechanisms, and treatment options.
• Analysis of the role of nutrition in oncologic care.
• Evaluation of pharmacologic agents investigated for CC management.

Main Results:

• No single standard treatment exists for CC.
• Pharmacologic agents targeting appetite and metabolism are foundational, but few are commercially available.
• Treatment choice depends on efficacy, QOL impact, side effects, cost, and availability.

Conclusions:

• Early identification and intervention for nutrition consequences are crucial in cancer patients.
• Pharmacologic treatments for CC are evolving, with a need for more effective and accessible agents.
• A multidisciplinary approach considering patient-specific factors is essential for managing cancer cachexia.